EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor

Term ID

CHEBI:138953

Synonyms

deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitor
deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitors
desamidonicotinamide adenine dinucleotide amidotransferase inhibitor
desamidonicotinamide adenine dinucleotide amidotransferase inhibitors
DPN synthetase inhibitor
DPN synthetase inhibitors
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitors
EC 6.3.5.1 inhibitor
EC 6.3.5.1 inhibitors
NAD synthetase (glutamine-hydrolysing) inhibitor
NAD synthetase (glutamine-hydrolysing) inhibitors
NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitor
NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitors
NAD(+) synthase (glutamine-hydrolysing) inhibitor
NAD(+) synthase (glutamine-hydrolysing) inhibitors
NAD(+) synthetase (glutamine-hydrolyzing) inhibitor
NAD(+) synthetase (glutamine-hydrolyzing) inhibitors
nicotinamide adenine dinucleotide synthetase (glutamine) inhibitor
nicotinamide adenine dinucleotide synthetase (glutamine) inhibitors

(all 19)

Definition

Any EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor that interferes with the action of NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor

EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor Show first 5 Terms
inverse has_role: 6-diazo-5-oxo-L-norleucine

6-diazo-5-oxo-L-norleucine Show first 5 Terms

Phenotype

Phenotype resulting from EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor

Phenotype where environments contain EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor

Phenotype modified by environments containing EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor

Human Disease Model